YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Schrodinger, Inc. SDGR shares soared 7.6% in the last trading session to close at $32.6. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 50.9% gain over the pas…
[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell on Tuesday. Stock index futures were mixed on Tuesday as investors awaited key economic rel…
Nyxoah REGULATED INFORMATION INSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company's strategic U.S. presence and focus Mont-Saint-Guibert, Belgium – September 28, 2026, 10:30 pm CET / 4:…
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S. post-approval study will evaluate Genio hypoglossal-nerve stimulation in adults aged 22 or older with moderate to…
Nyxoah NYXH recently initiated its U.S. post-approval BREATHE study with the first patient implanted using the Genio system, marking an important step in expanding clinical evidence for its obstructive sleep apnea therapy following FDA app…
Nyxoah Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System BREATHE is scheduled to implant up to 229 patients at up to 25 U.S. centers, followed for up to five years, to evaluate the long-…
Nyxoah SA (NYXH) shares jumped 15% in Wednesday trading after it said its ACCCESS US pivotal study m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Inspire Medical Systems, Inc. INSP raised its 2026 outlook after second-quarter results exceeded expectations. Better cost control, a richer mix of Inspire V implants and stronger cash generation helped offset a continued decline in U.S. p…
Key Points Interested in Nyxoah SA? Here are five stocks we like better. Nyxoah said its U.S. Genio launch is gaining traction, citing 262 trained surgeons, 123 ordering customers, and 427 patients in prior authorization. Management also s…
INFORMATIONS RÉGLEMENTÉES Le 19 juin 2026, 22:30h CET / 16:30h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l'assemblée générale ext…
REGULATED INFORMATION June 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “Company”) Invitation to attend the extraordinary shareholders’…
Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement Ce financement par dette non dilutif complète l’augmentation de capital de la Société réalisée en juin, portant le montant total des fonds levés à 110 millions d…
Nyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements the Company’s June equity raise, bringing total capital raised to $110 million Mont-Saint-Guibert, Belgium – June 17, 2026, 10:05 pm CET /…
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 10 juin 2026, 23h00 CET / 17h00 ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des…
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert(Belgium), June 10, 2026, 11:00 pm CET / 5:00 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large sh…
110 Millions de Dollars de Financements Cumulés pour Accélérer le Lancement Commercial de Genio aux États-Unis Mont-Saint-Guibert, Belgique – 10 juin 2026, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou…
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch Mont-Saint-Guibert, Belgium – June 10, 2026, 10:30 pm CET / 04:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical t…
Nyxoah SA (NYXH) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.63 per share a year ago. These figures are adjusted for non-recurring items. This quar…
INFORMATIONS RÉGLEMENTÉES Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026 Le lancement réussi de Genio aux États-Unis génère une croissance trimestrielle séquentielle de 25 % du chiffre d'affaires américai…
REGULATED INFORMATION Nyxoah Reports First Quarter 2026 Financial and Operating Results Strong Genio launch in the U.S. drove 25% sequential quarterly U.S. revenue growth Continued clarity around HGNS and Genio reimbursement in the U.S. Mo…
INFORMATIONS RÉGLEMENTÉES Le 8 mai 2026, 22:05h CET / 16:05h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l'assemblée générale annue…
REGULATED INFORMATION May 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “Company”) Invitation to attend the annual and the extraordinary…
Wall Street expects a year-over-year increase in earnings on higher revenues when Nyxoah SA (NYXH) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings p…
Tenet Healthcare (THC) came out with quarterly earnings of $4.82 per share, beating the Zacks Consensus Estimate of $4.21 per share. This compares to earnings of $4.36 per share a year ago. These figures are adjusted for non-recurring item…
Nyxoah SA (NASDAQ:NYXH) is one of the 7 Fastest Growing European Stocks to Invest In. On March 23, 2026, Baird analyst David Rescott lowered the price target on Nyxoah SA (NASDAQ:NYXH) to $4.62 from $5.87 and maintained a Neutral rating, c…
Nyxoah logo Key Points Nyxoah's U.S. launch is underway targeting ~400 high‑volume sites; the company covered 125 target accounts early, secured >70 VAC approvals with active implants at 50+ accounts, and reported $4.5 million of U.S. reve…
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert(Belgium), March 20, 2026, 10:30 pm CET / 5:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdin…
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert(Belgique), le 20 mars 2026, 22:30h CET / 17:30h ET– Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des partici…
Image source: The Motley Fool. DATE Thursday, March 19, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Olivier Taelman Chief Financial Officer — John Landry Need a quote from a Motley Fool analyst? Email pr@fool.com Full…
Image source: The Motley Fool. DATE Thursday, March 19, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Olivier TaelmanChief Financial Officer — John Landry Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAW…
Nyxoah logo Key Points Nyxoah received U.S. FDA approval for Genio on Aug. 8, 2025 and began U.S. commercialization (first implants/revenue in Sept 2025); by Dec. 31 the company had trained 145 surgeons across 125 high‑volume accounts and…
Nyxoah SA (NYXH) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items. This quar…
Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industrial…
INFORMATION RÉGLEMENTÉE Publication relative à une notification de transparence Mont-Saint-Guibert(Belgique), le 13 mars 2026, 22:30h CET / 17:30h ET– Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des particip…
REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert(Belgium), March 13, 2026, 10:30 pm CET / 5:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdin…
NyxoahtoParticipateinthe Oppenheimer36thAnnualHealthcareMedTech& Services Conference Mont-Saint-Guibert, Belgium – March 11, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medica…